Clinical Trial

A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

Name: A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia — clinical trial record (NCT07441980)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Clinical Study to Investigate the Safety and Efficacy of CT1390B in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Trial Details

NCT Number	NCT07441980
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Relapsed/Refractory Acute Myeloid Leukemia(AML)
Enrollment	18 participants
Start Date	2026-03-02
Primary Completion	2026-12-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-02